Novartis India share price surges nearly 11% to hit a 52-week high as Novartis AG announces sale plans for the co
Novartis AG's 70.68 percent stake in the business will be evaluated as part of the strategic review, the pharmaceutical giant stated in a statement.
DNA News Desk
0
3
Novartis AG's 70.68 percent stake in the business will be evaluated as part of the strategic review, the pharmaceutical giant stated in a statement.
